PeptideDB

Batabulin sodium

CAS No.: 195533-98-3

Batabulin sodium (T138067 sodium) is an antitumor agent, which covalently and selectively modifies the β-tubulin isotyp
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Batabulin sodium (T138067 sodium) is an antitumor agent, which covalently and selectively modifies the β-tubulin isotypes, thereby disrupting microtubule polymerization. Batabulin sodium affects cell morphology and leads to cell-cycle arrest ultimately induces apoptotic cell death [1].
In vitro Batabulin (T138067; 30-300 nM; 24 hours; MCF7 cells) treatment exhibits approximately 25-30% tetraploid (4n) DNA content in cells, suggesting an arrest at the G2/M cell-cycle boundary [1]. Batabulin (T138067; 30-300 nM; 24-48 hours; MCF7 cells) treatment shows 25-30% apoptosis. After a 48-hr exposure to 100 nM Batabulin, approximately 50-80% of the cell population is undergoing apoptosis [1]. Batabulin (T138067) binds covalently and selectively to a subset of the β-tubulin isotypes, thereby disrupting microtubule polymerization. Covalent modification occurs at a conserved Cys-239 shared by the β1, β2, and β4 tubulin isotypes. Cells exposed to Batabulin become altered in shape, indicating a collapse of the cytoskeleton, and show an increase in chromosomal ploidy [1]. Cell Cycle Analysis [1] Cell Line: MCF7 cells Concentration: 30 nM, 100 nM and 300 nM Incubation Time: 24 hours Result: Showed an arrest at the G2/M cell-cycle boundary. Apoptosis Analysis [1] Cell Line: MCF7 cells Concentration: 30 nM, 100 nM and 300 nM Incubation Time: 24 hours or 48 hours Result: 25-30% of cells showed the reduced DNA content characteristic of apoptotic cells.
In vivo Batabulin (T138067; 40 mg/kg; intraperitoneal injection; once per week; on days 5, 12, and 19; male athymic nude mice) treatment impairs the drug-sensitive CCRF-CEM tumors growth [1]. Animal Model: Male athymic nude mice ( nu/nu ) (6-8 week-old, 20-25 g) injected with CCRF-CEM cells [1] Dosage: 40 mg/kg Administration: Intraperitoneal injection; once per week; on days 5, 12, and 19 Result: Impaired the growth of the drug-sensitive CCRF-CEM tumors.
molecular weight 393.24
Molecular formula C13H6F6NNaO3S
CAS 195533-98-3
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year